JR Rahn is co-founder, director, and Co-CEO of the psychedelic research company MindMed.

MindMed is leading their drug discovery and development teams in conducting clinical trials and other research on candidate psychedelics for therapeutic use.

Check out MindMed: https://www.mindmed.co/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

JR Rahn is co-founder, director, and Co-CEO of the psychedelic research company MindMed. MindMed is leading their drug discovery and development teams in conducting clinical trials and other research on candidate psychedelics for therapeutic use. Check out MindMed: https://www.mindmed.co/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode 5 - JR Rahn

You may know Jon Najarian as a top authority on trading stocks and options from CNBC, but his interests go way beyond that. In his podcast series Compound Interests, he goes one-on-one with some of the biggest names in finance, sports, and more to provide an in-depth and personal look at motivation, winning and what's ahead.

Share Episode 5 - JR Rahn

Sign up to save your podcasts

Episode 5 - JR Rahn

Episode 5 - JR Rahn